Knowledge of Pregnant Women Concerning Pertussis, Vaccination Against Pertussis and Cocooning Strategy
NCT ID: NCT06114160
Last Updated: 2023-11-07
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
500 participants
OBSERVATIONAL
2023-12-01
2024-05-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
This vaccination schedule is inspired by the Anglo-Saxon model and studies showing the effectiveness of this practice.
The aim of this vaccine is to protect the newborn by transferring antibodies from the fetus to the placenta, because Pertussis is a particularly serious disease in newborns.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Pertussis (Tdap) Vaccination in Pregnancy
NCT01698346
Optimising the Timing of Whooping Cough Immunisation in MUMs
NCT03908164
Pediatric Pertussis in Ambulatory Settings
NCT04807712
GriCoVax Study in 4 Maternity Wards in the Ile-de-France Region
NCT04494581
Pertussis Vaccination in Pregnant Women
NCT03909126
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
pregnant women
Pregnant women between 20 and 41 weeks of amenorrhoea, primiparous.
Data collection
Data collection
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Data collection
Data collection
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Primiparous
* aged more than 18
* Agreed to participate in the study
Exclusion Criteria
* Protected by law (guardianship, guardianship, safeguarding of justice)
* Not agreed to participate in this study
18 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Université de Reims Champagne-Ardenne
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Pilet Caroline, midwife
Role: PRINCIPAL_INVESTIGATOR
CHU de Reims
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2023_RIPH_015_Coqueluche-Vac
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.